Concepedia

Andrew G. Lynn

AG

Statistics

Publications

7

Citations

222

H-Index

7

Active since

1978

Affiliations

Reckitt Benckiser (Netherlands)(Current)

Andrew G. Lynn is an author at Reckitt Benckiser (Netherlands) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

MedicinePharmacologyPhysiologyNeuropharmacologyMolecular PharmacologyNeuroscienceEndocrinologyDrug DiscoveryBiochemistryNervous System

Publications per year

1978–1983

7

Publications

7

Neuropharmacological studies in rodents on the action of RX 781094, a new selective α2-adrenoceptor antagonist

Peter W. Dettmar, Andrew G. Lynn, I.F. Tulloch · Neuropharmacology · 1983 · 61 citations

Molecular Pharmacology, Neuropeptides, Medicine +9

Neuropharmacological evaluation of RX 77368—a stabilised analogue of thyrotropin-releasing hormone (TRH)

Geoffrey Metcalf, Peter W. Dettmar, D. Fortune et al. · Regulatory Peptides · 1982 · 42 citations

Rx 77368—A, Molecular Pharmacology, Thyrotropin-releasing Hormone +8

Thyrotropin-releasing hormone (TRH) analogues show enhanced CNS selectivity because of increased biological stability

Geoffrey Metcalf, Peter W. Dettmar, Andrew G. Lynn et al. · Regulatory Peptides · 1981 · 35 citations

Molecular Neuroscience, Increased Biological Stability, Neurophysiology +15

Modification of the proline residue of TRH enhances biological activity and inhibits degradation

David Brewster, Peter W. Dettmar, Andrew G. Lynn et al. · European Journal of Pharmacology · 1980 · 31 citations

Proline Residue, Inhibits Degradation, Biochemistry +5

Opiate analgesics: the effect of agonist-antagonist character on prolactin secretion

B Brown, P W Dettmar, Pauline R.M. Dobson et al. · Journal of Pharmacy and Pharmacology · 1978 · 24 citations

Pain Medicine, Pharmacotherapy, System Pharmacology +19

Rows per page

1–5 of 7